Martini Silvia, Aggravi Marianna, Cianetti Simona, Egan William, Meppen Malte, Moriconi Alessio, Simeone Luca, Berti Francesco
Technical R&D, GSK Vaccines S.r.l., Via Fiorentina 1, 53100, Siena, Italy.
ACS Omega. 2019 Jul 29;4(7):12827-12832. doi: 10.1021/acsomega.9b01678. eCollection 2019 Jul 31.
The use of multivalent glycoconjugate vaccines has dramatically contributed to reduce the incidence of meningococcal infectious disease. The advanced structural characterization of polysaccharide conjugates leads to enhancements in the quality and control of the products. Here, we report a novel nuclear magnetic resonance (NMR) method to confirm the identity and structural conformity (e.g., -acetyl content) of saccharide antigens that comprise a licensed tetravalent meningococcal serogroups A, C, W, and Y vaccine. For the first time, the NMR methodology is applied on a formulation (licensed vaccine) containing a large excess of excipient (i.e., sucrose) without analytical sample pretreatment. This work confirms the applicability of a rapid and easy NMR assay on a multivalent conjugate vaccine, which might be extended to other combination vaccines that are already licensed or in clinical development.
多价糖缀合物疫苗的使用极大地有助于降低脑膜炎球菌感染性疾病的发病率。多糖缀合物的先进结构表征提高了产品的质量和控制水平。在此,我们报告了一种新型核磁共振(NMR)方法,用于确认构成已获许可的四价A、C、W和Y群脑膜炎球菌疫苗的糖抗原的身份和结构一致性(例如,乙酰含量)。首次在未经分析样品预处理的情况下,将NMR方法应用于含有大量赋形剂(即蔗糖)的制剂(已获许可的疫苗)。这项工作证实了快速简便的NMR检测方法在多价缀合物疫苗上的适用性,该方法可能会扩展到其他已获许可或正在临床开发的联合疫苗。